Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

McKesson recalls Inflectra (infliximab-dyyb)

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
cGMP Deviations: Product intended for quarantine was inadvertently distributed.
Products
  • Inflectra (infliximab-dyyb)
Company
McKesson
Where it was sold

Nationwide USA

Nationwide

Units affected
192 vials
About this recall
Inflectra (infliximab-dyyb), For injection, 100mg per vial, packaged in 10 mL single-dose vial, Rx only, Mfd by: CELLTRION, INC, Dist. by: Pfizer Labs, Division of Pfizer Inc., New York, NY 10001, NDC 0069-0809-01